Hepatitis B surface antigen (HBsAg), the major coat protein of hepatitis B virus, is also secreted from cells as a subviral particle, without concomitant cleavage of N-terminal amino acid sequences. We examined this unusual export process in a cell-free system and showed that the initial product of HBsAg biosynthesis is an integral transmembrane protein, with most or all of its C-terminal half on the lumenal side of the endoplasmic reticulum membrane. To study the nature of its topogenic signals, we synthesized fusion proteins between HBsAg and the nonsecreted protein alpha-globin. Fusion proteins in which approximately 100 amino acids of globin preceded all HBsAg sequences were successfully translocated in vitro; the same domain as in the wild-type HBsAg was transported into the vesicle lumen. Fusions in which the entire globin domain was C terminal were able to translocate both the C-terminal region of HBsAg and its attached globin domain. Thus, uncleaved signal sequences in p24s function to direct portions of the molecule across the membrane and are able to perform this function even when positioned in an internal protein domain.
Hepatitis B surface antigen (HBsAg), the major coat protein of hepatitis B virus, is also secreted from cells as a subviral particle, without concomitant cleavage of N-terminal amino acid sequences. We examined this unusual export process in a cell-free system and showed that the initial product of HBsAg biosynthesis is an integral transmembrane protein, with most or all of its C-terminal half on the lumenal side of the endoplasmic reticulum membrane. To study the nature of its topogenic signals, we synthesized fusion proteins between HBsAg and the nonsecreted protein alpha-globin. Fusion proteins in which approximately 100 amino acids of globin preceded all HBsAg sequences were successfully translocated in vitro; the same domain as in the wild-type HBsAg was transported into the vesicle lumen. Fusions in which the entire globin domain was C terminal were able to translocate both the C-terminal region of HBsAg and its attached globin domain. Thus, uncleaved signal sequences in p24s function to direct portions of the molecule across the membrane and are able to perform this function even when positioned in an internal protein domain.
One of the unique features of hepatitis B virus (HBV) infection is that, in addition to the elaboration of HBV virions, infected cells also synthesize and secrete massive quantities of small subviral particles (35) . These particles lack nucleic acid and are composed principally of the major viral coat protein, known as hepatitis B surface antigen (HBsAg), in close association with host-derived lipids (12, 34) . Although a great deal is known about the structure of HBsAg, relatively little attention has been paid to the mechanisms by which this protein is exported from cells. However, what information is available suggests that this process has features which may be of considerable interest.
HBsAg is a hydrophobic protein of 24 kilodaltons (kDa) which exists in serum in both an unglycosylated form (termed p24') and its glycosylated derivative (gp27S) (33) . Sequence analysis of cloned HBV DNA (11, 30, 42) has revealed that the coding region for p24s is preceded by an in-phase, contiguous open reading frame, termed presurface (or pre-S), which is capable of encoding at least two larger proteins containing p24s sequences at their C termini (Fig.  1A ). These proteins, p31Pre-s and p39Pre-S, are synthesized in small quantities in vivo and, like p24S, are also glycosylated, assembled into particles, and secreted (14, 23, 40) . No precursor-product relationship exists between these larger proteins and p24s. Each is synthesized by an independent translation initiation at its corresponding AUG codon (32) . In addition, when p24s coding sequences alone are cloned into simian virus 40-based expression vectors, they can direct the normal synthesis and export of 22-nm HBsAg particles (18, 22) . Thus, pre-S sequences are not required for the synthesis of p24s and cannot serve as signal sequences to direct its secretion; such signals must reside within the p24s coding region itself. Interestingly, comparison of the Nterminal amino acid sequence of secreted p24s (34) with the HBV DNA sequence reveals that, unlike the export of most proteins (2) , no amino acids are cleaved from the polypeptide during export. These unusual features led us to examine the export of the * Corresponding author.
surface-pre-S protein family in more detail, since this process raises interesting questions concerning the position dependence of topogenic signal sequences (1) . Although the location of export signals within the p24s molecule is not yet known (given the absence of signal cleavage), such elements must be situated internally within the larger pre-S proteins. Can export information within the p24' sequence function when so positioned, and if so, for which protein domains can it mediate transmembrane translocation? As a first step in addressing these issues, we have studied the transmembrane transport of p24' in a cell-free translation-coupled translocation system (43) . Using this system we demonstrated that this exported protein is not, as might have been predicted, directly secreted as such into the endoplasmic reticulum (ER) lumen. Rather, it is initially synthesized as an integral transmembrane protein in a process which results in the translocation of most or all of the C-terminal half of the molecule into the ER lumen. Using genetically engineered fusions between HBsAg and the cytoplasmic protein alpha-globin, we showed that HBsAg sequences can mediate the translocation of C-terminal domains of the hybrid polypeptide when positioned at either its N or C terminus. Thus, in HBsAg, uncleaved signal sequences function to direct domains in the C-terminal half of the molecule across the membrane and can perform this function even when positioned in an internal protein domain.
MATERIALS AND METHODS
Plasmid constructions. Plasmids pSP65 and pSP64, containing the bacteriophage SP6 promoter, were obtained from Promega Biotech. All restriction enzymes were purchased from New England BioLabs, Inc. and used according to the directions of the manufacturer. Plasmid pSP24H was derived by BamHI and EcoRI cleavage of pSP65, followed by ligation of the cleavage products to the 2.0-kilobase fragment of HBV DNA generated by cleavage of pEC63 (42) 8 ], 500 mM NaCl, 1 mM phenylmethylsulfonyl fluoride) at 4°C overnight. After incubation with protein A-Sepharose (Pharmacia) for 1 h, reaction mixtures were centrifuged at 10,000 x g for 5 min through a cushion of 35% (wt/vol) sucrose in RIPA buffer. Pellets were washed three times with RIPA buffer and two times with 1 mM Tris (pH 8)-0.1 mM EDTA-1 mM phenylmethylsulfonyl fluoride). The last wash was transferred to a fresh tube to avoid pelleted aggregates, and the final pellet was dried in vacuo before suspension in SDS loading buffer and electrophoresis, as described above.
RESULTS
In vitro translation of p24S. To study p24s translocation we employed an in vitro coupled transcription-translation system analogous to those previously described (20, 43) for the analysis of secretory and membrane proteins. In this system, synthetic p24s mRNA is generated by in vitro transcription with bacteriophage SP6 polymerase (27) of a recombinant plasmid in which p24s coding sequences are cloned downstream of a bacteriophage SP6 promoter (Fig. 1B) ; the resulting RNA is then used to program an in vitro translation extract (derived from wheat germ embryos) with or without added canine pancreatic microsomal vesicles. Together, these components contain all of the enzymatic machinery required for the transmembrane translocation of proteins. Translation products are radiolabeled with [35S]methionine and identified by immunoprecipitation and SDS-polyacrylamide gel electrophoresis. Translocation of the protein into the lumen of the vesicle can be assayed in two ways: (i) since the enzymatic apparatus for glycosylation is localized to the interior of the vesicle, glycosylation of p24s to gp27s (detected by the corresponding electrophoretic mobility shift) indicates translocation into the lumen; and (ii) protein domains transported into the lumen of the intact vesicle become resistant to attack by exogenously added proteases under conditions where untranslocated domains are digested.
In the absence of added membranes (Fig. 2 , lane 5), the major radiolabeled product of translation of synthetic p24S mRNA was a protein of 24 kDa, which immunoprecipitation with anti-HBsAg antibodies confirmed to be p24s (lane 1). When an identical translation was carried out in the presence of microsomes (lane 6), in addition to the 24-kDa species, a new species of 27 kDa was detected; this latter species, which typically accounts for 15 to 25% of the products, was also immunoprecipitable with anti-HBsAg (lane 3). To confirm that this new species was indeed gp27s, the N-linked glycosylation product of p24s, we treated the translation products made in the presence of microsomes with endoglycosidase H, which cleaves asparagine-linked highmannose carbohydrate chains (41) . This treatment resulted in the disappearance of the 27-kDa species with an increase in the intensity of the p24s band (Fig. 4, lanes 8 and 9) . We next examined whether glycosylation of p24s could proceed posttranslationally. In this experiment, translation was performed without membranes for 2.5 h; at this point, when no further incorporation of [35S]methionine label was detectable (data not shown), microsomal vesicles were added, and incubation continued for an additional 1 h. Electrophoretic analysis of the products (lane 2, and Fig. 3 , lane 3) revealed no gp27s under these conditions, indicating that (i) no leakage of glycosylation enzymes outside of the vesicles occurs during incubation and that (ii) translocationglycosylation of p24S is cotranslational. Preliminary experiments indicate that this cotranslational process involves interaction with signal recognition particle; addition of signal recognition particle in vitro translation extracts programmed with p24s mRNA results in translation arrest (44) , which is relieved by the addition of microsomal membranes (unpublished data).
To confirm that gp27s was indeed translocated into or across the membrane of the vesicle, we next examined the translocated products for resistance to exogenous trypsin (Fig. 3) . Under standard conditions trypsin is known to cleave p24s only once, after lysine 122, despite the large number of other arg and lys residues in the protein (33) . When p24S made in the absence of membranes (lane 2) was exposed to trypsin, p24s was completely cleaved to its expected limit products (lane 1). When membranes were present during translation, gp27S was seen as expected (lane 4) . When the labeled translocated products were exposed to trypsin (lane 5), gp27s remained intact under conditions in which p24s was virtually completely cleaved. If, however, after translation in the presence of membranes, the vesicles were first disrupted with nonionic detergent (Nikkol) before trypsin exposure, both gp27s and p24s were cleaved (lane 6) . Taken together, the data shown in Fig. 2 and 3 demonstrate that the cotranslational glycosylation of p24s is accompanied by translocation of at least the protein domain surrounding Iys122 (the trypsin site) and asnl46 (the glycosylation site) into the lumen of the vesicle.
Translocated p24S is an integral transmembrane protein. As noted above, since trypsin cleaves HBsAg at only one site, use of trypsin resistance as a criterion of membrane transport only probes the translocation of a limited region of the molecule. To determine if the entire molecule is translocated into the lumen (as for other secretory proteins), we next assayed the translocated products for resistance to proteinase K, a protease of lesser sequence specificity which was expected to attack the molecule at a different array of sites. This was indeed so (Fig. 4) ; labeled p24s synthesized in the absence of membranes (lane 1) was cleaved to different (and somewhat smaller) products after the addition of exogenous proteinase K (lanes 2 and 3) . Interestingly, even this potent protease did not cleave HBsAg to oligopeptide products under these conditions, but rather generated a series of discrete limit digest products-another reflection of the known protease resistance of this polypeptide (33) . Although these fragments were not efficiently immunoprecipitated by polyclonal antisera to native HBsAg particles (Fig. 6 , lanes 7 and 9), they could be detected in longer exposures of such gels (data not shown). Translation of HBsAg mRNA in the presence of microsomal vesicles (lane 4) again generated the expected products, p24s and gp27s; however, when these products were exposed to exogenous proteinase K, neither product was fully protected. Rather, in addition to limit products of p24s digestion, a protected band (Ro), ca. 7 kDa smaller than gp27s, was observed (lane 5 Transcripts of pSP24H were translated in vitro as described in the legend to Fig. 2 , and radiolabeled products that were made in the absence (lanes 1 and 2) or presence (lanes 4 to 6) of microsomal vesicles were either exposed (lanes 1, 5, and 6) or not exposed (lanes 2 to 4) to trypsin before electrophoresis and autoradiography; vesicles in lane 3 were added posttranslationally (PT). In lane 6, after translation in the presence of membranes (membr), the vesicles were disrupted by detergent (det) before exposure to trypsin. 4 . Proteolysis of translocated p24S by proteinase K. In vitro transcripts of pSP24H were translated in vitro in the presence (lanes 4 to 6 and 8, 9, and C) or absence (lanes 1, 2, and 7) of microsomal membranes (membr); in lane 3, membranes were added posttranslationally (PT). After translation the products were either exposed (lanes 2, 3, 5 to 9, and C) or not exposed (lanes 1 and 4) to proteinase K (PK), and the resulting products were electrophoresed directly (left panel) or after immunoprecipitation with either antiHBsAg (H) or nonimmune (N) serum (right panel). In lanes 6 and 9, products translated in the presence of microsomes were treated with detergent (det) to disrupt the vesicles before proteolysis. Ro denotes the protease-resistant fragment of gp27s resulting from membrane translocation.
sumed to result from altered cleavage efficiency at certain sites, has previously been observed with other translocated proteins in vitro [21] and does not alter the central conclusions of these experiments.) To ensure that this finding did not result from limited permeability of our vesicle preparations to proteinase K (or failure to completely inactivate the enzyme before opening the vesicles), we carried out control experiments in parallel with prolactin, a secretory protein known to be translocated entirely into the vesicle lumen. Addition of proteinase K to this preparation, under conditions identical to those used for p24s and gp27s, completely degraded preprolactin, but did not cleave the mature (translocated) prolactin (data not shown). For both p24s (lane 6) and prolactin (not shown), the protected fragment was attacked only when proteinase K was added after disruption of the vesicle preparation with Nikkol.
The demonstration that gp27s is only partially protected from proteinase K (Fig. 4) indicates that only a portion of the molecule is translocated into the vesicle lumen; that is, that transported HBsAg is a transmembrane protein which spans the membrane at least once. Together with the results of Fig.  2 contain p24s sequences at their C termini. Since p24s contains sequences which mediate transmembrane insertion, we sought to explore whether such topogenic sequences could retain their function when presented in an internal protein domain, analogous to their position in the pre-S proteins. Accordingly, we decided to test fusion proteins constructed by joining HBsAg amino acid sequences to those of the nonsecreted cytoplasmic protein alpha-globin. This polypeptide has no topogenic sequences of its own, but previous studies (20) have shown that the entire globin polypeptide can be transported across the vesicle membrane if fused downstream of (heterologous) N-terminal signal sequences; this indicates that no sequences inhibitory to translocation exist within the molecule, making it an ideal fusion partner for these experiments. In the first set of experiments, fusion proteins were synthesized which contained alpha-globin sequences at their N termini and HBsAg domains at their C termini. These proteins were generated by first preparing in vitro a recombinant plasmid (pSPglo24) in which surface antigen coding sequences were cloned 3' to a chimpanzee alpha-globin cDNA clone, which in turn was positioned immediately downstream of the phage SP6 promoter (Fig. 5) .
To fuse the coding regions, we cleaved the recombinant with BstEII, which cuts once within the 3' end of the globin gene, and with PstI, which cleaves in the distal pre-S region; the cleaved plasmid was further resected with Bal 31 nuclease, and the resulting shortened products were recloned in E. coli. Candidate fusion proteins were identified by transcribing individual recombinant plasmids in vitro with SP6 polymerase, followed by in vitro translation of the resulting hybrid mRNAs. Radiolabeled translation products of the appropriate size were screened for in-phase fusions by immunoprecipitation with antiglobin and anti-HbsAg antisera; this allowed the rapid screening of many recombinants without the need for DNA sequencing. The fusion junctions of in-phase chimeras were determined by restriction map-MOL. CELL. BIOL. ping and, where indicated, by DNA sequencing, to precisely locate the globin-HBsAg boundary.
Three in-phase fusions with fusion junctions in the distal pre-S region were recovered. All three were then examined in the in vitro translocation assay previously described, and representative data for fusion B8 are shown in Fig. 6B . Translation of B8 mRNA in the absence of membranes gave rise to a radiolabeled product of ca. 34 kDa (lane 2) which was precipitable with both antiglobin (lane 7) and antiHBsAg (lane 5) antisera. When translation was performed in the presence of microsomes, in addition to the 34-kDa band another, more slowly migrating band of ca. 37 kDa was seen (lane 3), which was also reactive with both antisera (lanes 8 and 6), as would be expected for the glycosylated (translocated) derivative of the fusion protein. To verify this, we treated the translocated products with endoglycosidase H (lane 4); the putative glycosylated product was indeed sensitive to endoglycosidase H digestion. As for wild-type p24', translocation was cotranslational: addition of membranes posttranslation did not result in the appearance of glycosylated products (lane 1).
All three globin-HBV fusions behaved similarly in the translocation assay (data not shown). Mutant B8, which contained the most extensive deletion of HBV DNA, was sequenced by the method of Maxam and Gilbert (25) , which revealed the fusion to join codon 97 of globin to a point 11 codons upstream of the p24 initiator methionine. More recently we have isolated and characterized fusions extending into p24s coding sequences, thus eliminating all pre-S residues. Similar analysis reveals that even a fusion joining 109 residues of globin to amino acid 51 of p24s is translocated in vitro (unpublished data). Since the alpha-globin sequence lacks potential sites for N-linked glycosylation, the observed glycosylation of the fusion proteins must reflect carbohydrate addition to the p24s domain, presumably at asnl46. Thus, these studies indicate that translocation of the Cterminal region of the fusion protein can be effected by topogenic signals within p24S, even when such signals are positioned in an internal protein domain. Further studies on the transmembrane orientation of these fusions are presented below.
Since the preceding studies indicate that substantial alterations at the N terminus of p24' do not abolish signal function, it was of interest to determine if additions of protein to the C terminus would likewise be tolerated. Accordingly, we generated gene fusions between p24' and globin in a recombinant SP6 plasmid vector (pSP24glo) in which the gene order is 5'-SP6 promoter-p24'-globin-3'. Figure 5 outlines the strategy used for fusing globin sequences to the distal portion of the p24S coding region in this vector. As before, candidate fusion plasmids were screened by coupled in vitro transcription-translation for protein products of the expected size that were immunoreactive with both globin and HBsAg antisera. Of four in-phase fusions initially recovered, two (mutants A23 and A28) were shown by restriction mapping (A23) or DNA sequencing (A28) to have preserved the p24 glycosylation site required for the glycosylation assay.
These recombinants produced fusion proteins of 36 kDa (A23) and 32 kDa (A28). Both underwent cotranslational glycosylation upon translation in the presence of microsomes (see Fig. 6A for data on A28). DNA sequence analysis of mutant A28 indicated that, in the protein encoded by this mutant, residue 165 of p24' is fused to the second amino acid of alpha-globin.
Transmembrane orientation of p24s-globin fusion proteins. We next sought to define the transmembrane orientation of the translocated fusion proteins to determine which protein domains were translocated under the influence of p24' signals. Our analysis exploited the availability of active fusions with globin-immunoreactive domains at either the N or C terminus; since the two halves of each fusion protein are differentially reactive with anti-HBsAg and antiglobin, these reagents can be used as probes for determining which portions of the translocated fusions are protected from protease attack. Accordingly, mutants A28 (N-HBsAgglobin-C) and B8 (N-globin-HBsAg-C) were selected for analysis; each mutant was transcribed with SP6 polymerase Translation products of fusions A28 (A) and B8 (B) made in the presence or absence of membranes (membr) as indicated above each figure were either exposed (lanes 2, 4, and 5) or not exposed (lanes 1 and 3) to proteinase K (PK) before electrophoresis; in both panels, products were analyzed without immunoprecipitation. Proteaseprotected fragments from fusion A28 (R1 and R2) and B8 (RO) are indicated, as are the positions of the full-size-glycosylated (gp) and unglycosylated (p) proteins. In lane 6 of each panel, the pattern of proteinase K digestion products of wild-type translocated p24s is displayed for comparison. Lanes are marked (det) for detergent treatment.
in vitro, and the product RNA was translated in vitro with or without added microsomes. Products were then treated with proteinase K, and the remaining protected species were identified by SDS-polyacrylamide gel electrophoresis before (Fig. 7) or after ( xpected, in the production of truncated species (labeled R, and R2), indicating that the fusion was not entirely sequestered within the vesicle. Immunoprecipitation of the protected fragments with antiglobin serum (Fig. 8A) 3) or after (lanes 2, 4, 5, and C) proteinase K digestion. After proteolysis, samples were immunoprecipitated with antiglobin (G) sera (lanes 1 and 2), anti-HBsAg (H) (lanesfor p24s itself, the HBsAg signal mediates translocation of at least the C-terminal portion of the molecule and confirms that there is no block to the transport of globin sequences in this system. Comparison of the molecular weights of the A28 polypeptides before and after proteinase K treatment indicates that, as in wild-type p24S, approximately 7 kDa of protein was removed by protease attack.
When the globin domain was at the N terminus of the hybrid polypeptide (mutant B), protease treatment of the translocated species also produced a truncated protected fragment (RO) (Fig. 7B, lane 4) . Two points, however, are noteworthy: (i) the size of this fragment was identical to that resulting from the protease treatment of translocated p24s itself (lane 6), and (ii) the fragment was reactive only with anti-HBsAg and not with antiglobin (Fig. 8B) Available electron microscopic evidence, while limited, suggests that 22-nm particles form within ER cisternae in infected cells (13, 16, 29) . Biochemical studies showing that high-mannose N-linked carbohydrates on HBsAg are processed to an endoglycosidase H-resistant form indicate that antigens destined for export likely traverse the Golgi apparatus (31) . Interestingly, the export of HBsAg proceeds much more slowly than does the processing of conventional secretory and membrane proteins, and analysis of the glycosylation pattern of accumulated intracellular p24s suggests a substantial delay in a pre-or early-Golgi processing step (31) . If transmembrane p24s on rough ER membranes is a precursor to particle formation, then major structural reorganization must occur to allow particle assembly: aggre- 
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-- Fig. 9B . These complex morphogenetic events could account at least in part for the observed delay in particle export.
We know of no other eucaryotic export process described to date which exactly resembles that of HBsAg, though transmembrane intermediates in the export of coat proteins of filamentous bacteriophages have been previously observed (37, 45 (28) and the transforming growth factor alpha (19) . However, in both these cases the secreted form of the protein is liberated from its membrane-bound precursor by proteolytic cleavage.
Transmembrane orientation of translocated HBsAg. Our studies indicate that at least the portion of p24s which includes lysl22 (the trypsin site) and asnl46 (the glycosylation site) is sequestered within the vesicle lumen. The protection of the globin domain from protease in fusion A28 indicates that the translocated segment of HBsAg must extend at least to amino acid 165 (the fusion junction); detailed studies are underway to determine if the extreme C terminus of p24s is also translocated. The experiments indicate that at least one transmembrane domain must be present upstream of lys122. Inspection of the predicted amino acid sequence of p24s reveals an extremely hydrophobic segment (from residues 80 to 100) which is likely to mediate this function.
The fact that the protease-protected domains of fusion B8 do not include identifiable globin sequences demonstrates that at least some domains N terminal to the transmembrane region are exposed on the cytoplasmic face of the membrane. However, the precise disposition of this N-terminal region with respect to the membrane remains to be clarified. Models in which single (Fig. 9A, model a) or multiple (Fig.  9A , models b and c) transmembrane segments exist are equally compatible with the data presented here. Although the failure of N-terminal sequences in fusion B8 to be protected from protease might argue against model b (Fig.  9A) , we consider it possible that such upstream globin domains might be translocated inefficiently relative to the wild-type N terminus and hence might be accessible to digestion. Further experiments to determine the fine structue of transmembrane HBsAg are in progress; it will be of considerable interest to compare its transmembrane topology with those of other proteins known to harbor uncleaved or internal signals (3, 5-8, 15, 24, 26) .
Topogenic signals in p24S in variety of contexts. Because p24s sequences are positioned internally in two distinct pre-S proteins (14) during natural HBV infection, we asked whether topogenic signals in p24s could function when positioned in an internal domain. Since the role of pre-S sequences themselves in translocation is uncertain, we replaced them with coding sequences (from alpha-globin) known to be devoid of signal function but nonetheless capable of being transported across the lipid bilayer when coupled to an active signal (20) . Our findings (Fig. 6 and 7 ) that hybrid globin-p24s proteins were translocated demonstrate that p24s sequences can function to translocate downstream protein domains even when positioned behind almost 100 amino acids of globin. The ability of HBsAg topogenic signals to function from within an internal protein domain may reflect an important property of signal sequences which direct the topology of other integral transmembrane proteins, especially those whose internal regions span the lipid bilayer many times; the existence of internal signal sequences has been proposed (1) to be responsible for the internal looping across the membrane of such "polytopic" membrane proteins.
As noted earlier, pre-S sequences are not required for p24S translocation. However, this does not exclude a role for pre-S sequences in the topogenesis of the larger pre-S proteins (p31PreS and p39PreS). Our data with globin-p24s fusions (e.g., B8) make it likely that, in the natural pre-S proteins, at least the C-terminal regions of the p24 domain will be translocated into the ER lumen. However, the orientation of the pre-S domains themselves may depend upon the presence or absence of additional topogenic signals within these sequences.
